Technology Highlights

Advanced Point-of-Care Molecular Systems for Clinical and Non-Clinical Applications

Key Highlights 

Our innovative, fully automated multiplex molecular diagnostic system enables the simultaneous detection of over 40 pathogens and has been recognised as a recipient of the inaugural RAISe+ Scheme. Already admitted for clinical use in both private and public hospitals and clinics across Hong Kong, we are now expanding into broader clinical, environmental, and veterinary applications, with ongoing enhancements to our system platforms to address unmet needs and advance global health resilience.

 

A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer
Challenges 
  • The absence of multiplex point-of-care diagnostics hinders rapid detection of infectious diseases
  • Existing methods are constrained by limited throughput, multiplexing capability, and/or accessibility
  • Comprehensive real-time surveillance solutions are lacking, impeding timely public health response
Breakthrough Technology
  • Simultaneous, multiplex detection of over 40 pathogens in a single run
  • Fully automated workflow from sample extraction to result interpretation
  • Innovative and proprietary biochemical and engineering technologies
  • Exceptional sensitivity and specificity for reliable diagnostic outcomes
  • Real-time surveillance and data-driven alert capabilities support public health response

 

Industry Applications
  • Clinical diagnostics for hospitals, clinics, laboratories
  • Public health surveillance and border controls
  • Outbreak response and pandemic preparedness
  • Other applications include environmental and veterinary testing
A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer
Business Benefits
  • Targeting the rapidly expanding global diagnostic market, facilitating efficient pointof-care testing
  • Versatile platform technology applicable to early cancer detection, antimicrobial resistance detection and additional areas
  • Deliver rapid results to enhance clinical decision-making and improve patient experience
  • Support decentralised testing, increasing accessibility in low-resource environments 
A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer A Novel Microfluidic Flow Cytometry Based Cell-Molecular Analyzer
Technology Readiness Level 8-9: System Test, Launch & Operations Technology Readiness Level 8-9: System Test, Launch & Operations
Team Leader

Professor Terence LT Lau, Interim Chief Innovation Officer; Director Wu Jieh Yee Institute of Translational Chinese Medicine Research 

Interested in Our Innovation?

Contact us at iit@hkbu.edu.hk to explore collaboration and partnership opportunities.

Back